Panda Smriti, Kumar Rajeev, Konkimalla Abhilash, Thakar Alok, Singh Chirom Amit, Sikka Kapil, Sharma Suresh C, Kakkar Aanchal, Bhasker Suman
1Department of Otolaryngology and Head and Neck Surgery, All India Institute of Medical Sciences, Teaching Block, 4th Floor, New Delhi, 110029 India.
2Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
Indian J Surg Oncol. 2019 Dec;10(4):608-613. doi: 10.1007/s13193-019-00935-4. Epub 2019 May 22.
Thyroidectomy conventionally accompanies total laryngectomy. This study intends to analyze the incidence and factors leading to thyroid gland involvement in carcinoma larynx and hypopharynx. Retrospective chart review from March 2011 to December 2016 of all patients who had undergone total laryngectomy at our institute. A total of 125 patients entered into the analysis. Subsites involved were glottis ( 32), supraglottis ( = 28), transglottis ( = 52), pyriform sinus ( = 12), and subglottis ( = 1). TNM distribution according to AJCC 7th edition is as follows: T2 ( 1), T3 ( = 34), T4 ( = 90); N0 ( = 97), N1 ( = 13), N2a ( = 5), N2b ( = 5), N2c ( = 4), and N3 ( = 1). Total thyroidectomy was performed in 16 patients, near total thyroidectomy in 5, and hemithyroidectomy in 104. Histopathologically thyroid gland involvement was seen in 11/125 (8.8%). The overall incidence of hypothyroidism was 48% (hemithyroidectomy, 43/104; total thyroidectomy, 16/16; near total thyroidectomy, 1/5). The incidence of permanent hypoparathyroidism was 12.8% (total thyroidectomy, 11; hemithyroidectomy, 5). On multivariate analysis (Cox proportional hazards model), extralaryngeal spread into level 6 (HR = 5.5, = .006, C.I = 1-18.8) and extracapsular extension (HR = 9.3, = 0.02, C.I = 1.29-67.5) were statistically significant predictors for thyroid gland involvement. Survival analysis of patients with thyroid gland involvement ( = 11) revealed 5-year overall survival (OS) of 100% and 5-year disease-free survival (DFS) of 59.3% compared with patients without thyroid gland involvement, 71% and 51.7%, respectively (median follow-up, 30 months). Thyroid gland involvement did not show a statistically significant effect on OS/DFS on multivariate analysis. In view of the endocrine abnormalities and lack of survival benefit seen, thyroidectomy should be performed judiciously during total laryngectomy.
传统上甲状腺切除术与全喉切除术同时进行。本研究旨在分析喉癌和下咽癌中甲状腺受累的发生率及相关因素。对2011年3月至2016年12月在我院接受全喉切除术的所有患者进行回顾性病历审查。共有125例患者纳入分析。受累亚部位包括声门(32例)、声门上区(28例)、跨声门(52例)、梨状窝(12例)和声门下区(1例)。根据美国癌症联合委员会第7版的TNM分布如下:T2(1例)、T3(34例)、T4(90例);N0(97例)、N1(13例)、N2a(5例)、N2b(5例)、N2c(4例)和N3(1例)。16例行全甲状腺切除术,5例行近全甲状腺切除术,104例行甲状腺次全切除术。组织病理学检查发现125例中有11例(8.8%)甲状腺受累。甲状腺功能减退的总体发生率为48%(甲状腺次全切除术,104例中有43例;全甲状腺切除术,16例中有16例;近全甲状腺切除术,5例中有1例)。永久性甲状旁腺功能减退的发生率为12.8%(全甲状腺切除术,11例;甲状腺次全切除术,5例)。多因素分析(Cox比例风险模型)显示,喉外扩散至6区(HR = 5.5,P = 0.006,CI = 1 - 18.8)和包膜外扩展(HR = 9.3,P = 0.02,CI = 1.29 - 67.5)是甲状腺受累的统计学显著预测因素。对甲状腺受累患者(n = 11)的生存分析显示,5年总生存率(OS)为100%,5年无病生存率(DFS)为59.3%,而未发生甲状腺受累的患者分别为71%和51.7%(中位随访时间30个月)。多因素分析显示,甲状腺受累对OS/DFS无统计学显著影响。鉴于观察到的内分泌异常和生存获益缺乏,在全喉切除术中应谨慎进行甲状腺切除术。